Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Light Study, a long-term research study of Contrave® (naltrexone SR/bupropion SR), a new, investigational drug being evaluated for weight loss, has begun enrolling patients at clinical sites throughout the United States. The Light Study is designed to assess the cardiovascular health outcomes of Contrave.
Nearly 93 million Americans are affected by obesity, and that number is predicted to increase to 120 million Americans within the next five years. More than one-third of adults in the United States are affected by obesity. Obesity increases the risk of heart disease, type 2 diabetes, some types of cancer, sleep apnea, and a variety of other conditions. Medical research suggests that losing just five percent of your body weight can significantly improve your health and reduce the risk of complications from type 2 diabetes and heart disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56480-lightstudy
http://youtu.be/tHPU2gR_RiI blu cigs National TV ad - I like to smoke but my old cigarettes kept me from smoking where I wanted to. blu electronic cigarettes are different. They have no ash and no offensive odor, so I can enjoy them anywhere. In my car, at work, at my favorite restaurant or even at my friends house. blu has lot's of great USA made flavors and come in four different strengths so I can control my nicotine intake and it cost less than regular cigarettes. blu is the smarter alternative to cigarettes and the best way to take back you're freedom. blu Cigs are available at many fine retailers including, Sheetz, Ingles, Kerr Drug, Harps, Cumberland Farms, H-E-B, Scolari's and Couche-Tard.
Presented here are few of the products which Vertex Product Development has designed, engineered and developed from conception to production for the Consumer, Commercial, Industrial and Medical industries.
